FMP
Nov 16, 2025(Last modified: Nov 17, 2025)
LifeMD, Inc. (NASDAQ:LFMD), a prominent figure in the virtual healthcare and pharmacy sector, is gearing up for its quarterly earnings announcement on November 17, 2025. Analysts are forecasting an earnings per share (EPS) of -$0.06 and revenue projections of around $62.1 million. The company's telehealth services have seen a surge in popularity, positioning it as a key player in the industry.
Recently, LifeMD, Inc. announced a rescheduling of its third-quarter earnings release and conference call to November 17, 2025. This adjustment is attributed to necessary corrections in revenue recognition and related balance sheet accounts, impacting periods ending December 31, 2023, December 31, 2024, and June 30, 2025, with a cumulative effect of approximately $4.6 million, or 1.4% of the cumulative revenue for those periods.
The financial metrics of LFMD reveal several challenges. The company's negative price-to-earnings (P/E) ratio stands at -30.66, indicating negative earnings. Its price-to-sales ratio is approximately 0.94, suggesting the market values the company slightly below its sales. The enterprise value to sales ratio is 0.88, showing a lower valuation when considering debt and cash.
Furthermore, the enterprise value to operating cash flow ratio is 10.54, reflecting the company's valuation in relation to its cash flow from operations. The earnings yield is at -3.26%, further emphasizing the negative earnings scenario. Additionally, the debt-to-equity ratio is -12.37, indicating a negative equity position, which may raise concerns among investors.
LFMD's liquidity situation is also a point of concern, with a current ratio of approximately 0.77. This suggests potential challenges in meeting short-term obligations, indicating that the company may struggle to cover its short-term liabilities with its current assets.
Accelerant Holdings (NASDAQ:ARX) is a company that focuses on providing innovative solutions in its industry. The compan...
Health Catalyst, Inc. (Nasdaq: HCAT) is a key player in the healthcare technology sector, providing data and analytics s...